肝癌介入灌注化疗栓塞术与无水酒精治疗肝癌的不良反应对比  

Comparison of Adverse Reactions between Interventional Chemoembolization and Anhydrous Alcohol in the Treatment of Hepatocellular Carcinoma

作　　者：刘德[1] 冯梓贤 刘军[2] 黄志红[1] 陆敏丽 张彩华[1] 曹传越 

机构地区：[1]廉江市人民医院放射介入科,廉江524400 [2]廉江市人民医院肿瘤科

出　　处：《数理医药学杂志》2018年第3期326-328,共3页Journal of Mathematical Medicine

摘　　要：目的:研究肝癌介入灌注化疗栓塞术(TACE)与无水酒精(PEI)治疗肝癌的不良反应对比。方法:将某院2016年3月~2016年12月患有肝癌的患者选取70例,分为对照组和实验组,实验组采用肝癌介入灌注化疗栓塞术,对照组采用无水酒精治疗,比较两组患者的不良反应。结果:两组患者术后,实验组的不良反应发生率为28.57%,对照组的不良反应发生率为51.43%,两组的不良反应发生率存在明显差异,且差异具有统计学意义。结论:介入灌注化疗栓塞术治疗肝癌的不良反应发生率小于无水酒精治疗肝癌,值得在临床上广泛推广应用。Objective:To compare the adverse reactions between interventional chemoembolization and anhydrous alcohol in the treatment of hepatocellular carcinoma.Methods:70 cases liver cancer patients treated in a hospital from March 2016 to December 2016 were divided into control group and experimental group.The experimental group was given interventional chemotherapy embolization surgery,the control group was given anhydrous alcohol treatment,then the adverse reactions of the two groups were compared.Results:The incidence of adverse reactions was 28.57 in the experimental group and 51.43%in the control group.There was a significant difference in the incidence of adverse reactions between the two groups,and the difference was statistically significant.Conclusion:The incidence of adverse reactions in interventional chemoembolization for liver cancer is lower than that in anhydrous alcohol,so it is worth popularizing in clinic.

关 键 词：肝癌 介入灌注化疗栓塞术 无水酒精治疗 不良反应发生率 

分 类 号：R735.7[医药卫生—肿瘤]